SeaStar Medical
44 hedge funds and large institutions have $90.2M invested in SeaStar Medical in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
16% more funds holding
Funds holding: 38 → 44 (+6)
0.04% more ownership
Funds ownership: 0.31% → 0.34% (+0.04%)
2% less capital invested
Capital invested by funds: $91.8M → $90.2M (-$1.56M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$1.83M |
| 2 |
LA
Linden Advisors
New York
|
+$1.49M |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$1.44M |
| 4 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$1.33M |
| 5 |
Walleye Trading
New York
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$965K |
| 2 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$493K |
| 3 |
D.E. Shaw & Co
New York
|
-$358K |
| 4 |
CCA
Cruiser Capital Advisors
Stamford,
Connecticut
|
-$326K |
| 5 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$301K |
ICU Hedge Fund Activity: Q4 2021 in Review
44 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q4 2021, worth a combined $90.2M — down 1.7% from $91.8M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ICU positions and 4 closed out — a net gain of 6 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Walleye Capital, opening a new position worth an estimated $1.83M. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $965K sold.
- 44 institutional investors held SeaStar Medical (ICU) as of Q4 2021, up from 38 in Q3 2021.
- Funds reported $90.2M of SeaStar Medical stock for Q4 2021, down 1.7% quarter-over-quarter.
- 10 funds opened new SeaStar Medical positions in Q4 2021 and 4 closed out, a net change of +6 holders.
- The largest SeaStar Medical buyer in Q4 2021 was Walleye Capital, an estimated $1.83M added.
- The largest SeaStar Medical seller in Q4 2021 was Wolverine Asset Management, an estimated $965K sold.
Based on aggregated 13F filings for Q4 2021.